MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 9, 2004; DOI: 10.1124/mol.104.002543


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.002543v1
66/4/988    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feng, H.-J.
Right arrow Articles by Macdonald, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, H.-J.
Right arrow Articles by Macdonald, R. L.


Received for publication May 12, 2004.
Revised July 7, 2004.
Accepted for publication July 8, 2004.

PENTOBARBITAL DIFFERENTIALLY MODULATES {alpha}1{beta}3{delta} AND {alpha}1{beta}3{gamma}2L GABAA RECEPTOR CURRENTS

Hua-Jun Feng 1, Matt T. Bianchi 1, Robert L. Macdonald 2*

1 Vanderbilt University Medical Center 2 Vanderbilt University

* Address correspondence to: E-mail: robert.macdonald{at}vanderbilt.edu

Abstract

GABAA receptors are modulated by a variety of compounds including the neurosteroids and barbiturates. Although the effects of barbiturates on {alpha}{beta}{gamma} isoforms, thought to dominate phasic (synaptic) GABAergic inhibition, have been extensively studied, the effects of pentobarbital on kinetic properties of {alpha}{beta}{delta} GABAA receptors, thought to mediate tonic (extra or peri-synaptic) inhibition, are unknown. Utilizing ultra-fast drug delivery and single channel recording techniques, we demonstrate isoform specific pentobarbital modulation of low efficacy, minimally desensitizing {alpha}1{beta}3{delta} currents and high efficacy, rapidly desensitizing {alpha}1{beta}3{gamma}2L currents. Specifically, with saturating concentrations of GABA, pentobarbital substantially potentiated peak {alpha}1{beta}3{delta} receptor currents but failed to potentiate peak {alpha}1{beta}3{gamma}2L receptor currents. Also, pentobarbital had opposite effects on the desensitization of {alpha}1{beta}3{delta} (increased) and {alpha}1{beta}3{gamma}2L (decreased) receptor currents evoked by saturating GABA. Pentobarbital increased steady-state {alpha}1{beta}3{delta} receptor single channel open duration primarily by introducing a longer-duration open state, while for {alpha}1{beta}3{gamma}2L receptor channels, pentobarbital increased mean open duration by increasing the proportion and duration of the longest open state. The data support previous suggestions that GABA may be a partial agonist at {alpha}{beta}{delta} isoforms, which may render them particularly sensitive to allosteric modulation. The remarkable increase in gating efficacy of {alpha}1{beta}3{delta} receptors suggests that {alpha}{beta}{delta} isoforms, and by inference tonic forms of inhibition, may be important targets for barbiturates.


Key words: GABAA, GABAC, Single channel kinetics, Barbiturates


This article has been cited by other articles:


Home page
J. Neurosci.Home page
H. P. Goodkin, S. Joshi, Z. Mtchedlishvili, J. Brar, and J. Kapur
Subunit-Specific Trafficking of GABAA Receptors during Status Epilepticus
J. Neurosci., March 5, 2008; 28(10): 2527 - 2538.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. T. Bianchi, E. J. Botzolakis, K. F. Haas, J. L. Fisher, and R. L. Macdonald
Microscopic kinetic determinants of macroscopic currents: insights from coupling and uncoupling of GABAA receptor desensitization and deactivation
J. Physiol., November 1, 2007; 584(3): 769 - 787.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Ter-Mikaelian, D. H. Sanes, and M. N. Semple
Transformation of Temporal Properties between Auditory Midbrain and Cortex in the Awake Mongolian Gerbil
J. Neurosci., June 6, 2007; 27(23): 6091 - 6102.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Akk, P. Li, B. D. Manion, A. S. Evers, and J. H. Steinbach
Ethanol Modulates the Interaction of the Endogenous Neurosteroid Allopregnanolone with the {alpha}1beta2{gamma}2L GABAA Receptor
Mol. Pharmacol., February 1, 2007; 71(2): 461 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. C. Drafts and J. L. Fisher
Identification of Structures within GABAA Receptor {alpha} Subunits That Regulate the Agonist Action of Pentobarbital
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1094 - 1101.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H.-J. Feng, J.-Q. Kang, L. Song, L. Dibbens, J. Mulley, and R. L. Macdonald
{delta} Subunit Susceptibility Variants E177A and R220H Associated with Complex Epilepsy Alter Channel Gating and Surface Expression of {alpha}4beta2{delta} GABAA Receptors
J. Neurosci., February 1, 2006; 26(5): 1499 - 1506.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Khom, I. Baburin, E. N. Timin, A. Hohaus, W. Sieghart, and S. Hering
Pharmacological Properties of GABAA Receptors Containing {gamma}1 Subunits
Mol. Pharmacol., February 1, 2006; 69(2): 640 - 649.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. A. Wagner, M. P. Goldschen-Ohm, T. G. Hales, and M. V. Jones
Kinetics and Spontaneous Open Probability Conferred by the {epsilon} Subunit of the GABAA Receptor
J. Neurosci., November 9, 2005; 25(45): 10462 - 10468.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H.-J. Feng and R. L. Macdonald
Multiple Actions of Propofol on {alpha}{beta}{gamma} and {alpha}{beta}{delta} GABAA Receptors
Mol. Pharmacol., December 1, 2004; 66(6): 1517 - 1524.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics